in3logo An integrated interdisciplinary approach to animal-free nanomaterial and chemical safety assessment.

::home::      ::progress::      ::partners::      ::training::      ::about in3::      .:ESTIV home:.     
The in3 project is funded by the EU's Marie Sklodowska-Curie Action - Innovative Training Network (MSCA-ITN for short)  that aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial (NM) safety assessment. Here are our dedicated, motivated, dynamic, early stage researchers.

  in3 session ESTIV 2018 Berlin

Come visit our in3 session at the 20th International Congress on In Vitro Toxicology (ESTIV2018) New approach methodologies for in vitro toxicology applications at the Estrel Hotel Berlin Sonnenallee 225, Berlin, Germany  Berlin, Wednesday 17th October 2018 @ 15:00 in the main auditorium.  All 15 ESRs will give a short presentation. Please come and visit our posters too P3, 6, 15, 16, 18, 23, 60, 61, 62, 175 and 226.

Hope to meet you there !


  1. Rauch, C., Feifel, E., Kern, G., Murphy, C., Meier, F., Parson, W., Beilmann, M., Jennings, P., Gstraunthaler, G., Wilmes, A., 2018. Differentiation of human iPSCs into functional podocytes. PLoS One 13, e0203869. doi:10.1371/journal.pone.0203869


in3 is funded by the Marie Sklodowska-Curie Action - Innovative Training Network under grant no. 721975.